Table 1: Demographic characteristics of acromegaly patients and control group.

Acromegaly
()
Control
()

Gender (, %)
 Female 31 (59.6)53 (63.9)
 Male 21 (40.4)30 (36.1)
Age (y)45.7 ± 1.943.1 ± 2.6
Age onset (y)39.5 ± 1.9
Tumor size before treatment (, %)
 Macroadenoma 36 (81.8)
 Microadenoma8 (18.2)
Number of resection (, %)
 0 8 (17.8)
 129 (64.4)
28 (17.8)
IGF1 (ng/mL)
 Before treatment882.5 ± 56
 After treatment234.6 ± 21.3
IGF1 (% ULN)
 Before treatment330.0 ± 21
 After treatment100.8 ± 10.4
GH (ng/mL)
 Before treatment 18.3 ± 2.9
 After treatment1.3 ± 0.2
Remission status (, %)
 Controlled36 (80)
 Uncontrolled9 (20)
Tumor size after treatment (, %)
 ≥1 cm 10 (22.7)
 <1 cm 34 (77.3)
25(OH)D3 (nmol/L)*5.5 ± 1.129.9 ± 2.1

Data are shown as mean ± standard error. IGF1 (%ULN): IGF1/upper limit of normal (age-matched) 100.
*.